- Investing Ideas
- /
- Real Estate Healthcare Sector
Real Estate Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Immunocore Holdings
Market Cap: US$1.5b
A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
IMCR
US$30.37
7D
6.9%
1Y
-43.0%
GoodRx Holdings
Market Cap: US$1.5b
Offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
GDRX
US$3.96
7D
-8.3%
1Y
-47.1%
Andlauer Healthcare Group
Market Cap: CA$2.1b
A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.
AND
CA$53.50
7D
0%
1Y
34.4%
Phreesia
Market Cap: US$1.5b
Provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
PHR
US$25.40
7D
-0.9%
1Y
4.5%
Travere Therapeutics
Market Cap: US$1.5b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$16.80
7D
-16.1%
1Y
177.2%
Regis Healthcare
Market Cap: AU$2.3b
Engages in the provision of residential aged care services in Australia.
REG
AU$7.73
7D
4.0%
1Y
89.5%
Ryman Healthcare
Market Cap: NZ$2.5b
Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly people in New Zealand and Australia.
RYM
NZ$2.45
7D
1.2%
1Y
-37.5%
Structure Therapeutics
Market Cap: US$1.4b
A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
GPCR
US$25.17
7D
-1.6%
1Y
-30.4%
Janux Therapeutics
Market Cap: US$1.4b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$24.28
7D
-5.0%
1Y
-48.5%
GRAIL
Market Cap: US$1.4b
A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
GRAL
US$39.91
7D
13.4%
1Y
n/a
Neogen
Market Cap: US$1.4b
Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
NEOG
US$6.61
7D
10.7%
1Y
-51.2%
Mesoblast
Market Cap: AU$2.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.73
7D
1.5%
1Y
59.4%
Indivior
Market Cap: UK£1.1b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
UK£8.45
7D
2.0%
1Y
-36.8%
Adaptive Biotechnologies
Market Cap: US$1.4b
A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
ADPT
US$9.05
7D
0.2%
1Y
150.7%
Celldex Therapeutics
Market Cap: US$1.4b
A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
CLDX
US$20.45
7D
11.6%
1Y
-46.5%
Astrana Health
Market Cap: US$1.4b
A healthcare management company, provides medical care services in the United States.
ASTH
US$27.18
7D
-8.5%
1Y
-33.5%
Vera Therapeutics
Market Cap: US$1.4b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
VERA
US$21.25
7D
-2.1%
1Y
-48.7%
Dyne Therapeutics
Market Cap: US$1.3b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$11.83
7D
3.7%
1Y
-57.3%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Green Thumb Industries
Market Cap: CA$1.9b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.90
7D
2.5%
1Y
-55.2%
ARS Pharmaceuticals
Market Cap: US$1.3b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$13.60
7D
1.2%
1Y
50.6%
MannKind
Market Cap: US$1.3b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$4.37
7D
-4.2%
1Y
-4.8%
Teladoc Health
Market Cap: US$1.3b
Provides virtual healthcare services worldwide.
TDOC
US$7.52
7D
5.8%
1Y
-40.9%
Omnicell
Market Cap: US$1.3b
Provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
OMCL
US$27.96
7D
8.5%
1Y
-8.1%
Heska
Market Cap: US$1.3b
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.
HSKA
US$119.99
7D
0.1%
1Y
39.9%
Kestra Medical Technologies
Market Cap: US$1.3b
Operates as a wearable medical device and digital healthcare company.
KMTS
US$24.62
7D
8.6%
1Y
n/a
Artivion
Market Cap: US$1.3b
Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
AORT
US$29.51
7D
2.1%
1Y
25.8%
Azenta
Market Cap: US$1.3b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
AZTA
US$27.47
7D
2.6%
1Y
-46.0%
Pediatrix Medical Group
Market Cap: US$1.3b
Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
MD
US$14.93
7D
2.8%
1Y
92.9%
dentalcorp Holdings
Market Cap: CA$1.7b
Through its subsidiaries, provides health care services by acquiring and partnering with dental practices in Canada.
DNTL
CA$8.58
7D
-2.6%
1Y
36.0%
U.S. Physical Therapy
Market Cap: US$1.2b
Operates and manages outpatient physical therapy clinics.
USPH
US$79.84
7D
7.8%
1Y
-25.2%
ANI Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$59.99
7D
-9.5%
1Y
-2.3%
Pacira BioSciences
Market Cap: US$1.2b
Engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States.
PCRX
US$25.86
7D
2.9%
1Y
-16.1%
AdaptHealth
Market Cap: US$1.2b
Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.
AHCO
US$9.02
7D
5.2%
1Y
-9.6%
CVS Group
Market Cap: UK£895.3m
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
CVSG
UK£12.48
7D
-4.0%
1Y
23.8%
Sienna Senior Living
Market Cap: CA$1.7b
Provides senior living services in Canada.
SIA
CA$17.93
7D
1.9%
1Y
20.0%